CAS 942918-07-2: N'-[4-[4-[2-[3-[(Dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethylurea

Fórmula: C₃₀H₃₃N₇O

InChI: InChI=1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38)

Sinónimos:

• 3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea
• Gsk-1070916A

GSK-1070916

CAS: 942918-07-2

• Fórmula: C₃₀H₃₃N₇O
• Pureza: 99%
• Forma y color: Solid
• Peso molecular: 507.6293

GSK-1070916

CAS: 942918-07-2

• Pureza: 98.5%
• Peso molecular: 507.63g/mol

GSK-1070916

CAS: 942918-07-2

GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 …

• Fórmula: C₃₀H₃₃N₇O
• Pureza: 99.73%
• Forma y color: Solid
• Peso molecular: 507.63

GSK 1070916

CAS: 942918-07-2

Potent and ATP-competitive inhibitor of Aurora kinase B and C

• Fórmula: C₃₀H₃₃N₇O
• Pureza: Min. 95%
• Forma y color: Solid
• Peso molecular: 507.63 g/mol